Eleclazine + Placebo to match eleclazine
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ventricular Arrhythmia
Conditions
Ventricular Arrhythmia
Trial Timeline
Sep 1, 2014 → Oct 1, 2016
NCT ID
NCT02104583About Eleclazine + Placebo to match eleclazine
Eleclazine + Placebo to match eleclazine is a phase 2 stage product being developed by Gilead Sciences for Ventricular Arrhythmia. The current trial status is completed. This product is registered under clinical trial identifier NCT02104583. Target conditions include Ventricular Arrhythmia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02104583 | Phase 2 | Completed |
Competing Products
20 competing products in Ventricular Arrhythmia